Adjunctive Dexmedetomidine in Alcohol Withdrawal Syndrome: A Systematic Review and Meta-analysis of Retrospective Cohort Studies and Randomized Controlled Trials

Objective: To investigate whether dexmedetomidine (DEX), as adjunctive therapy to benzodiazepine (BZD), is superior to BZD alone in critically ill patients with alcohol withdrawal syndrome (AWS). Data Sources: PubMed Central, Cochrane CENTRAL, ClinicalTrials.gov and Google Scholar were used as searc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of Pharmacotherapy 2023-06, Vol.57 (6), p.696-705
Hauptverfasser:	Polintan, Edgar Theodore T., Danganan, Lester Mico L., Cruz, Nikki S., Macapagal, Sharina C., Catahay, Jesus Alfonso, Patarroyo-Aponte, Gabriel, Azmaiparashvili, Zurab, Lo, Kevin Bryan
Format:	Artikel
Sprache:	eng
Schlagworte:	Benzodiazepines - therapeutic use Cohort Studies Dexmedetomidine - adverse effects Humans Randomized Controlled Trials as Topic Substance Withdrawal Syndrome - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!